Globus Medical Inc
GMED· NYSE
Released Oct 28, 2020, after the close
10-Q filed Oct 28, 2020, 28 days after period end · 0001237831-20-000063
| Metric | Q3 2020 | Q3 2017 | Q3 2016 | Q3 2015 |
|---|---|---|---|---|
| Revenue | $216.10M | $151.74M | $135.65M | $136.99M |
| Net Income | $44.22M | $25.59M | $26.23M | $26.48M |
| EPS Diluted |
Globus Medical Inc · CIK 1237831 · Engraved from SEC EDGAR
| $0.44 |
| $0.26 |
| $0.27 |
| $0.28 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.